You are here

Structurally Diverse Encoded Peptide Sets

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43GM106421-01
Agency Tracking Number: R43GM106421
Amount: $151,352.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: NIGMS
Solicitation Number: PA12-088
Solicitation Year: 2013
Award Year: 2013
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
CHAPEL HILL, NC 27514-3912
United States
DUNS: 962655853
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 (919) 962-8682
Business Contact
Phone: (919) 924-2828
Research Institution

DESCRIPTION (provided by applicant): Cell Microsystems is a North Carolina-based start-up biotechnology company whose mission is to commercialize a novel, yet affordable, platform for the efficient isolation of viable, single cells or colonies from a mixedpopulation while the cell/colony remains adherent or encapsulated to a solid surface. The company's IsoRaft technology is based on a unique cell array recently developed at the University of North Carolina (UNC) at Chapel Hill, and represents an ideal opportunity for the translation of an academic technology to the marketplace through the SBIR program. Cell Microsystems has obtained license from UNC to commercialize the technology for a broad market in academic labs, as well as in the biotechnology and pharmaceutical industries. The products consist of disposable microarray (the IsoRaft Array) for culturing cells and a simple device for isolating the cell/colony of interest. Prototypes of arrays and devices have been completed and are being tested in a number of academic labs as an Early Adoption Program (EPA) at nearby research institutes. In this Phase I SBIR proposal, we will explore the feasibility of using the IsoRaft technology for stem cell research. Particularly we will focus on design and optimize the IsoRaft Array for stem cells, and develop strategies for cell imaging, identification, tracking and retrievl of targeted stem cells/colonies. The use IsoRaft technology for stem cell research will be conducted by our academic collaborator at UNC School of Medicine. Our goal is to expand the use of this technology for stem cell research to the large community in the life science market. The studies in Phase I will deliver a 1st generation commercial device and consumables that provide a flexible and powerful means to perform unique stem cell assay and sorting experiments at significant cost and time reduction. PUBLIC HEALTH RELEVANCE PUBLIC HEALTH RELEVANCE: The novel cell sorting technology being developed by Cell Microsystems Inc. will havebroad applications in various health and scientific related area of research.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government